Results 51 to 60 of about 12,689 (257)
, 2023 Incremental cost effectiveness ratio for patient mortality (percentage) from a healthcare perspective.
Sarah Foster (102634) +8 more
core +1 more source
Arthritis Care &Research, EarlyView.Systemic sclerosis (SSc) is a rare autoimmune disease defined by immune dysregulation, vasculopathy, and progressive fibrosis of the skin and internal organs. Despite advances in care, major complications such as interstitial lung disease (ILD) and myocardial involvement remain the leading causes of morbidity and mortality.
Cristiana Sieiro Santos +2 more
wiley +1 more source
Pharmacoeconomic evaluation of treatments for Poly Cystic Ovarian Syndrome (PCOS)
Cost Effectiveness and Resource AllocationBackground Treatment cost and high prevalence of Poly Cystic Ovarian Syndrome (PCOS) is a very challenging issue globally. Due to this reason; current study was conducted to determine pharmaco-economy of conventional and non-conventional treatments for ...
Darakhshan Masroor +4 more
doaj +1 more source
PLoS ONE, 2015 BackgroundBiologics are used for the treatment of inflammatory bowel diseases, Crohn´s disease and ulcerative colitis refractory to conventional treatment.
Saara Huoponen, Marja Blom
doaj +1 more source
Expert Review of Pharmacoeconomics & Outcomes Research, 2022 There is controversy on whether to use incremental monetary net benefit (INMB) or incremental cost-effectiveness ratio (ICER) in health economic evaluations alongside randomized controlled trials. We studied the impact of restricted mean survival time (RMST) on the long-term projection of INMB and ICER.
Fei Yuan +3 more
openaire +2 more sources
, 2016 Probabilistic sensitivity analysis frequency and cumulative frequency of incremental cost-effectiveness ratio (ICER: incremental cost-effectiveness ratio; LYG: life-year gained).
Karine Chevreul (561200) +3 more
core +1 more source
Arthritis Care &Research, EarlyView.Objective Race and household income impact outcomes in patients with rheumatic conditions; however, their role in pediatric antineutrophil cytoplasmic antibody (ANCA)–associated vasculitis (AAV) remains poorly understood. We aimed to evaluate whether race and ethnicity and household income are associated with severe AAV disease and renal outcomes among
Roberto Alejandro Valdovinos +2 more
wiley +1 more source
On Projection of Costs and Incremental Cost-Effectiveness Ratios: A Data Example [PDF]
International Journal of Health Sciences (IJHS), 2015 Cost and cost-effectiveness analysis has been more and more important to both policy makers and clinicians in assessing health care delivery. The incremental costeffectiveness ratio (ICER) is widely used inpractice to evaluate the relative health benefit of one treatment over another.
openaire +1 more source
Average costs, outputs and incremental cost-effectiveness ratio (ICER).
, 2015 Average costs, outputs and incremental cost-effectiveness ratio (ICER).
Anna Thorson (102699) +8 more
core +1 more source
Cost effectiveness of outpatient lumbar discectomy [PDF]
, 2021 Background: Microdiscectomy is the most commonly performed spine surgery and the first transitioning for outpatient settings. However, this transition was never studied, in what comes to cost-utility assessment.
Fonseca, JA +6 more
core +1 more source